http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101404263-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-26
filingDate 2008-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101404263-B1
titleOfInvention (1R) -2- (4-methoxyphenyl) -l-methylethyl] amino] ethyl] -2 (lH) -dihydroxy- Process for preparing quinolinone monohydrochloride
abstract The present invention provides a process for the preparation of more convenient CHF4226 with a similar methodology, including the following step according to Scheme 1, instead of the process disclosed in EP 0147719.n n n (a) reacting a compound of formula (XII), wherein X is a halogen atom selected from the group consisting of fluorine, chlorine, bromine and iodine, and R is a hydroxyl-protecting group, to obtain a compound of formula (XIII) '), Wherein R' is an amino-protecting group;n n n (b) reducing the compound to obtain a compound of formula (XIV) which already has the correct (R), (R) configuration;n n n (c) deprotecting compound (XIV) to obtain compound (I);n n n The (R), (R) diastereomeric selectivity of compound (XIV) is at least 60%, preferably at least 80%, even more preferably at least 90%, most preferably at least 95%.n n n Preferably, the (R), (R) diastereomeric selectivity is further increased by recrystallization of compound (I) and compound (XIV), more preferably by recrystallization of compound (XIV).n n n Preferably, the hydroxyl-protecting group R is selected from the group consisting of benzyl, p-methoxybenzyl, 3,4-dimethoxybenzyl, p- or o-nitrobenzyl, benzyloxycarbonyl and p-methoxybenzyloxycarbonyl Lt; RTI ID = 0.0 &gt; phenyl &lt; / RTI &gt; lower alkyl. Preferably, the amino-protecting group R &apos; is a substituted or unsubstituted alkyl group selected from the group consisting of benzyl, p-methoxybenzyl, p-fluorobenzyl, p- chlorobenzyl, p- bromobenzyl, diphenylmethyl and naphthylmethyl Unsubstituted phenyl lower alkyl.n n n More preferably, R = R 'and even more preferably R and R' are benzyl groups.n n n In one preferred embodiment, the R and R 'protecting groups are simultaneously removed. In a more preferred embodiment, the deprotection is catalytic debenzylation.n n n The present invention further relates to the compound (XIII) and the compound (XIV) obtained as a stable intermediate of the above-mentioned reaction.n n n Quinolinone monohydrochloride, Tanabe, CHF4226
priorityDate 2007-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0147719-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18755291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14661518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419656506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455824799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453173728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426690638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454671498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414806636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4148881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9898815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454231118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23670382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456371369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455667478

Total number of triples: 50.